Anavex Life Sciences Corp (AVXL)

[nidan7500]

Interview brings out what a long/uphill slog it must be for RSD kids/parents and medical staff who are looking for a glimmer of hope in an effective treatment. Dr. Hagerman impressed as feet on the ground practitioner certainly capable of multi-processing the options available. Her messages (significant improvements, breakthrough, sooner the better) all convey a sense of urgency.

They all really need better tools to measure progress and change at multiple levels. Points out how critical the PDD Actigraphy data could be.